AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20415156 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickest rubber glove (3.1 mm)
Number of subjects: 7
Study 20415156 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickest interdigital spacers
Number of subjects: 7
Study 20415156 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing glove thickness during submaximal object-lifting task
Number of subjects: 7
Study 20415156 — intervention group
Group type: EXPERIMENTAL
Intervention: All gloves (increased thickness)
Number of subjects: 7
Study 16835670 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-centred surveillance and treatment
Number of subjects: 127
Study 16835670 — intervention group
Group type: COMPARATOR
Intervention: Control group (primary care physician follow-up)
Number of subjects: 127
Study 16835670 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endpoint (LDL-C < 2.5 mmol/L, triglycerides < 2.0 mmol/L, total cholesterol/HDL < 4.0)
Number of subjects: 127
Study 15074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoreqing oral liquid (NRQ)
Number of subjects: 451
Study 15074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoreqing oral liquid (NRQ) plus western medicine (WM)
Number of subjects: 451
Study 15074086 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (WM) alone
Number of subjects: 451
Study 10732177 — intervention group
Group type: EXPERIMENTAL
Intervention: Early tactile stimulation
Number of subjects: 49
Study 10732177 — intervention group
Group type: COMPARATOR
Intervention: Routine conventional therapy
Number of subjects: 49
Study 8882986 — intervention group
Group type: EXPERIMENTAL
Intervention: CT plus IFN alpha‐2a (3 MU/m2 twice weekly)
Number of subjects: 90
Study 8882986 — intervention group
Group type: COMPARATOR
Intervention: CT alone
Number of subjects: 90
Study 1356319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 24
Study 1356319 — intervention group
Group type: COMPARATOR
Intervention: Control (thiopental, nitrous oxide, oxygen, and fentanyl)
Number of subjects: 24
Study 1356319 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 2408735 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with methotrexate, bleomycin, and cisplatin
Number of subjects: 163
Study 2408735 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 163
Study 3324523 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g single dose of amoxicillin
Number of subjects: 91
Study 3324523 — intervention group
Group type: COMPARATOR
Intervention: 4-day course of 3 doses of 750 mg amoxicillin
Number of subjects: 91
Study 29564846 — intervention group
Group type: EXPERIMENTAL
Intervention: CON/CON (concentric quadriceps and concentric hamstrings, n=10)
Number of subjects: 40
Study 29564846 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC/ECC (eccentric quadriceps and eccentric hamstrings, n=10)
Number of subjects: 40
Study 29564846 — intervention group
Group type: EXPERIMENTAL
Intervention: CON/ECC (concentric quadriceps and eccentric hamstrings, n=10)
Number of subjects: 40
Study 29564846 — intervention group
Group type: COMPARATOR
Intervention: CTRL (no training, n=10)
Number of subjects: 40
Study 28842126 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postpartum levonorgestrel intrauterine device insertion
Number of subjects: 259
Study 28842126 — intervention group
Group type: COMPARATOR
Intervention: Delayed postpartum levonorgestrel intrauterine device insertion
Number of subjects: 259
Study 26152218 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 1 mg
Number of subjects: 150
Study 26152218 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 2 mg
Number of subjects: 150
Study 26152218 — intervention group
Group type: COMPARATOR
Intervention: IV saline (Control group)
Number of subjects: 150
Study 23782128 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release methylphenidate (MPH)
Number of subjects: 24
Study 23782128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21587283 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (INT) with individual advice on healthy diet and physical activity for 4.1 years.
Number of subjects: 147
Study 21587283 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) with no specific intervention.
Number of subjects: 147
Study 21587283 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (INT)
Number of subjects: 147
Study 18423697 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg dutasteride
Number of subjects: 99
Study 18423697 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride
Number of subjects: 99
Study 18423697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 18423697 — intervention group
Group type: EXPERIMENTAL
Intervention: 5alpha-reductase inhibitors (dutasteride and finasteride)
Number of subjects: 99
Study 16929628 — intervention group
Group type: EXPERIMENTAL
Intervention: Eagle's syndrome group (n=10)
Number of subjects: 20
Study 16929628 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (n=10)
Number of subjects: 20
Study 14679474 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and pyrazinamide
Number of subjects: 0
Study 10711705 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ‐123 (60 microg/min)
Number of subjects: 15
Study 10711705 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ‐123 (120 microg/min)
Number of subjects: 15
Study 10711705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9199074 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 1 x 40 mg per day
Number of subjects: 226
Study 9199074 — intervention group
Group type: COMPARATOR
Intervention: Na-heparin 3 x 5000 IE (increased to 3 x 7500 IE if PTT did not reach 40 seconds)
Number of subjects: 226
Study 1376845 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (0.4 mg)
Number of subjects: 12
Study 1376845 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (2.0 mg)
Number of subjects: 12
Study 3888386 — intervention group
Group type: EXPERIMENTAL
Intervention: CFP (cyclophosphamide, 5-FU, and prednisone)
Number of subjects: 125
Study 3888386 — intervention group
Group type: COMPARATOR
Intervention: CFP plus tamoxifen
Number of subjects: 125
Study 31208433 — intervention group
Group type: EXPERIMENTAL
Intervention: Minima S short-stem
Number of subjects: 0
Study 31208433 — intervention group
Group type: COMPARATOR
Intervention: Trilock Bone Preservation Stem
Number of subjects: 0
Study 28687281 — intervention group
Group type: EXPERIMENTAL
Intervention: Head CT with generalised oedema
Number of subjects: 356
Study 28687281 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak NSE >38ng/l
Number of subjects: 356
Study 28687281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of peak NSE >38ng/l and generalised oedema on CT
Number of subjects: 356
Study 26410604 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI + OMT
Number of subjects: 1052
Study 26410604 — intervention group
Group type: COMPARATOR
Intervention: OMT
Number of subjects: 1052
Study 23588803 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional psychological interventions (pain management training, biofeedback)
Number of subjects: 0
Study 23588803 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent developments (sensory discrimination training, mirror treatment, graded motor imagery, prosthesis training, training in virtual reality)
Number of subjects: 0
Study 21329022 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery (GI)
Number of subjects: 12
Study 21329022 — intervention group
Group type: COMPARATOR
Intervention: Music group (control)
Number of subjects: 12
Study 19808455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein antrum isolation (PVAI)
Number of subjects: 103
Study 19808455 — intervention group
Group type: EXPERIMENTAL
Intervention: PVAI followed by CFAEs
Number of subjects: 103
Study 19808455 — intervention group
Group type: COMPARATOR
Intervention: Complex fractionated atrial electrograms (CFAEs)
Number of subjects: 103
Study 17342992 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Shenhua Tablet (SHT)
Number of subjects: 131
Study 17342992 — intervention group
Group type: COMPARATOR
Intervention: Fosinopril (positive control)
Number of subjects: 131
Study 14990014 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 10-20 mg orally three times a day for 7 days
Number of subjects: 30
Study 14990014 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.05 mg subcutaneously two times a day for 3 days
Number of subjects: 30
Study 14990014 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 mg subcutaneously two times a day for 3 days
Number of subjects: 30
Study 11772796 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of midazolam (M group)
Number of subjects: 50
Study 11772796 — intervention group
Group type: COMPARATOR
Intervention: Midazolam vehicle (P group)
Number of subjects: 50
Study 10322686 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination in urban DSPs
Number of subjects: 112
Study 10322686 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination in rural DSPs
Number of subjects: 112
Study 10322686 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of neonates vaccination against HB program with routine EPI in urban DSPs
Number of subjects: 112
Study 10322686 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of neonates vaccination against HB program with routine EPI in rural DSPs
Number of subjects: 112
Study 8574122 — intervention group
Group type: EXPERIMENTAL
Intervention: Air dive to a pressure of 0.49 MPa for 40 min with a decompression stop of 5 min at 0.16 MPa and 10 min at 0.13 MPa.
Number of subjects: 12
Study 8574122 — intervention group
Group type: COMPARATOR
Intervention: Control exposure breathing O2 at atmospheric pressure for 40 min.
Number of subjects: 12
Study 2649317 — intervention group
Group type: EXPERIMENTAL
Intervention: buspirone (24.5 mg daily)
Number of subjects: 367
Study 2649317 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (20.8 mg daily, range 10 mg to 60 mg)
Number of subjects: 367
Study 2649317 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 367
Study 715070 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal suppositories of 15(S)15 methyl prostaglandin F2 alpha methyl ester (50 cases)
Number of subjects: 100
Study 715070 — intervention group
Group type: COMPARATOR
Intervention: Primary surgery (50 cases)
Number of subjects: 100
Study 30636746 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective perception of grip force exertion using % Maximum Voluntary Contraction (MVC)
Number of subjects: 9
Study 29045302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (add-on treatment)
Number of subjects: 53
Study 29045302 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 53
Study 26388424 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine (mesalamine)
Number of subjects: 0
Study 26388424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23870532 — intervention group
Group type: EXPERIMENTAL
Intervention: Real attention bias retraining
Number of subjects: 0
Study 23870532 — intervention group
Group type: EXPERIMENTAL
Intervention: Real alcohol/no-go training
Number of subjects: 0
Study 23870532 — intervention group
Group type: EXPERIMENTAL
Intervention: Real approach bias retraining
Number of subjects: 0
Study 23870532 — intervention group
Group type: COMPARATOR
Intervention: Placebo attention bias retraining
Number of subjects: 0
Study 23870532 — intervention group
Group type: COMPARATOR
Intervention: Placebo alcohol/no-go training
Number of subjects: 0
Study 23870532 — intervention group
Group type: COMPARATOR
Intervention: Placebo approach bias retraining
Number of subjects: 0
Study 23870532 — intervention group
Group type: EXPERIMENTAL
Intervention: All real CBM conditions
Number of subjects: 0
Study 23870532 — intervention group
Group type: COMPARATOR
Intervention: All placebo conditions
Number of subjects: 0
Study 23870532 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of participants drinking within sensible drinking limits
Number of subjects: 0
Study 21821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteroscopic retrieval under local anesthesia
Number of subjects: 67
Study 21821994 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopic retrieval under local anesthesia
Number of subjects: 67
Study 21821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of flexible instruments
Number of subjects: 67
Study 21821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of rigid instruments
Number of subjects: 67
Study 21821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per use of flexible instruments
Number of subjects: 67
Study 21821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per use of rigid instruments
Number of subjects: 67
Study 19708035 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence therapy
Number of subjects: 0
Study 19708035 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 17941026 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of liposomal amphotericin B (AmB) at 3 mg/kg daily and caspofungin at standard dose
Number of subjects: 30
Study 17941026 — intervention group
Group type: COMPARATOR
Intervention: High-dose monotherapy with liposomal amphotericin B at 10 mg/kg daily
Number of subjects: 30
Study 15030339 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine
Number of subjects: 993
Study 15030339 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole pulse
Number of subjects: 993
Study 15030339 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole continuous
Number of subjects: 993
Study 15030339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 993
Study 15030339 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin
Number of subjects: 993
Study 11564124 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (1,000-3,000 mg/day)
Number of subjects: 0
Study 9636808 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with standardized grass-pollen extract
Number of subjects: 136
Study 9636808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 7868848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tacrine (25 and 50 mg b.i.d.)
Number of subjects: 8
Study 7868848 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal tacrine (12.5 and 25 mg b.i.d.)
Number of subjects: 8
Study 7868848 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal tacrine
Number of subjects: 8
Study 7868848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tacrine
Number of subjects: 8
Study 3122548 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 111
Study 3122548 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 111
Study 29506013 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal women
Number of subjects: 15
Study 29506013 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 15
Study 28625234 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (GEDVI guidance)
Number of subjects: 40
Study 28625234 — intervention group
Group type: COMPARATOR
Intervention: Control group (CVP guidance)
Number of subjects: 40
Study 26507186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient vitamin D levels (>30 ng/ml)
Number of subjects: 237
Study 26507186 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient vitamin D (<30 ng/ml)
Number of subjects: 237
Study 26507186 — intervention group
Group type: EXPERIMENTAL
Intervention: Deficient vitamin D (<20 ng/ml)
Number of subjects: 237
Study 26507186 — intervention group
Group type: EXPERIMENTAL
Intervention: Each 1 ng/ml increase in 25(OH)D
Number of subjects: 237
Study 26507186 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin D status
Number of subjects: 237
Study 22879576 — intervention group
Group type: EXPERIMENTAL
Intervention: FRESH START diet and exercise intervention
Number of subjects: 452
Study 20849470 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg controlled-release levodopa/carbidopa
Number of subjects: 32
Study 20849470 — intervention group
Group type: COMPARATOR
Intervention: Off-state (no treatment)
Number of subjects: 32
Study 18463553 — intervention group
Group type: EXPERIMENTAL
Intervention: KR33%
Number of subjects: 40
Study 18463553 — intervention group
Group type: COMPARATOR
Intervention: GD100%
Number of subjects: 40
Study 18463553 — intervention group
Group type: COMPARATOR
Intervention: GD33%
Number of subjects: 40
Study 18463553 — intervention group
Group type: COMPARATOR
Intervention: KR100%
Number of subjects: 40
Study 16467101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendritic cell-MFP therapy
Number of subjects: 10
Study 12643965 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal feedback about blushing (participants told they had blushed)
Number of subjects: 56
Study 12643965 — intervention group
Group type: COMPARATOR
Intervention: Verbal feedback about blushing (participants told they had not blushed)
Number of subjects: 56
Study 12643965 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal feedback about blushing
Number of subjects: 56
Study 10861142 — intervention group
Group type: EXPERIMENTAL
Intervention: Face Mask (FM)
Number of subjects: 300
Study 10861142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway with fully inflated cuff (LMA-High)
Number of subjects: 300
Study 10861142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway with semi-inflated cuff (LMA-Low)
Number of subjects: 300
Study 10861142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA-Low)
Number of subjects: 300
Study 9359722 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin plus clofazimine plus ethambutol (three-drug arm)
Number of subjects: 95
Study 9359722 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin plus clofazimine (two-drug arm)
Number of subjects: 95
Study 7994648 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Vit B2 5mg three times a day during phototherapy
Number of subjects: 34
Study 7994648 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Vit B2)
Number of subjects: 34
Study 2657838 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg/day, flexible to 30 mg/day, mean daily dose 20.5 mg)
Number of subjects: 50
Study 2657838 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 50
Study 2657838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 820622 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH injection
Number of subjects: 44
Study 820622 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 44
Study 31438912 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First with Assertive Community Treatment (HF with ACT)
Number of subjects: 201
Study 31438912 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 201
Study 29049251 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 0.5mg/kg
Number of subjects: 16
Study 25902771 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over M1
Number of subjects: 24
Study 25902771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over M1
Number of subjects: 24
Study 25902771 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS over M1
Number of subjects: 24
Study 25902771 — intervention group
Group type: EXPERIMENTAL
Intervention: All tDCS types (anodal, cathodal, sham)
Number of subjects: 24
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers' recovery attitudes
Number of subjects: 82
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving experiences
Number of subjects: 82
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of contacts with affected relative
Number of subjects: 82
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of psychotic symptoms
Number of subjects: 82
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a partner
Number of subjects: 82
Study 23179046 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime history of mental disorder
Number of subjects: 82
Study 22043463 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless implant placement
Number of subjects: 40
Study 22043463 — intervention group
Group type: COMPARATOR
Intervention: Open flap implant placement
Number of subjects: 40
Study 19424716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen breathing (HOB)
Number of subjects: 19
Study 19424716 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen breathing (NOB)
Number of subjects: 19
Study 19424716 — intervention group
Group type: COMPARATOR
Intervention: Control dives
Number of subjects: 19
Study 16731470 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (high PAC activity)
Number of subjects: 112
Study 16731470 — intervention group
Group type: COMPARATOR
Intervention: Group B (moderate PAC activity)
Number of subjects: 112
Study 16731470 — intervention group
Group type: COMPARATOR
Intervention: Group C (low PAC activity)
Number of subjects: 112
Study 15193485 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol valerate/dienogest
Number of subjects: 0
Study 15193485 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol/norethisterone acetate
Number of subjects: 0
Study 10674960 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CX) mouthrinse
Number of subjects: 0
Study 10674960 — intervention group
Group type: COMPARATOR
Intervention: Cetyl pyridinium chloride (CPC) mouthrinse
Number of subjects: 0
Study 10674960 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (0.05% BC) mouthrinse
Number of subjects: 0
Study 10674960 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (0.1% BC) mouthrinse
Number of subjects: 0
Study 7857222 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous recombinant growth hormone (rGH) 0.2 iu/kg daily for 7 days
Number of subjects: 15
Study 7857222 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) injection daily for 7 days
Number of subjects: 15